Confident Pain Management

Treating Pain is at the
Heart of Medicine

Medasense is the developer of a unique technology that objectively monitors and quantifies the patient’s pain response level using artificial intelligence algorithms and a proprietary noninvasive sensor platform.

NOL technology is used to optimize pain management in critical care settings, where anaesthetized patients are unable to communicate.

Interface connectivity is enabled with Philips patient monitors, enabling a consolidated view of changes in pain response level alongside vital signs.

The technology is distributed across Europe exclusively by Medtronic, and by leading partners in other regions.
DISTRIBUTION MAP

nol technology

Eliminate guesswork and meet clinical challenges in assessing pain and optimizing analgesia.

CLINICAL EVIDENCE

MEDASENSE ACADEMY

Welcome to our online and customized education and training program for clinicians and commercial partners.

Latest News

Study validates NOL technology for assessment of pain in mechanically ventilated patients

>

Medasense has been awarded a development grant to extend the application of its NOL pain

>

MedTech Innovator selected Medasense for its innovation and accomplishments, as one of 50 top companies

>

Global Distribution Network

Medasense Global Distribution Map

Video Highlights

The essence of Medasense: Guiding critical care clinicians for optimal pain care

Meeting the challenge of intraoperative pain monitoring

Leading clinicians on the importance of monitoring the patient’s pain response level

Clinical Collaborations

REFERENCES:
1. Meijer, F., Martini, C., Broens, S., Boon, M., Niesters, M., Aarts, L., Olofsen, E., van Velzen, M., Dahan, A. (2019). Nociception-guided versus Standard Care during Remifentanil–Propofol Anesthesia: A Randomized Controlled Trial. Anesthesiology, 130(5), 745-755. doi:10.1097/ALN.0000000000002634